To gain insight into the intricate molecular mechanism by which HSPB1 regulated doxorubicin-induced ferroptosis, we first explored whether HSPB1 was able to regulate NF-κB pathway to exhibit a tumor-promoting role in breast cancer. Here, NFKB1 is linked to breast carcinoma.